Skip to main content
. 2022 May 18;7(8):1802–1818. doi: 10.1016/j.ekir.2022.05.011

Table 4.

Association of the rs4293393 (A/G) UMOD variant with key clinical phenotypes across sex groups in non-Hispanic White patients in the MVP

Females
Clinical phenotypes PheWAS code description Cases Controls OR (95% CI) per copy of the A allele P value
CKD CKD 1685 28,924 1.30 (1.18–1.44) 2.87 × 10−07,a
CKD, stage III 1154 29,725 1.25 (1.10–1.45) 2.39 × 10−04
CKD, stage IV 263 31,007 1.62 (1.24–2.11) 4.00 × 10−04
Hypertensive complications Hypertensive CKD 774 30,108 1.28 (1.11–1.49) 7.50 × 10−04
Hypertensive heart or renal disease 1567 28,773 1.17 (1.06–1.30) 2.20 × 10−03
UTIs UTI 7840 18,560 0.98 (0.98–1.05) 4.03 × 10−01
Cystitis 977 28,707 0.87 (0.78–0.98) 2.01 × 10−02
Acute cystitis 245 30,151 0.84 (0.68–1.05) 1.31 × 10−01
Pyelonephritis 584 30,061 0.92 (0.79–1.07) 2.62 × 10−01
Urinary calculi Urinary calculus 1990 28,328 0.86 (0.79–0.93) 1.73 × 10−04
Calculus of the kidney 1710 28,751 0.84 (0.77–0.91) 4.98 × 10−05,a
Calculus of the ureter 518 30,514 0.77 (0.66–0.89) 5.37 × 10−04
Males
Clinical phenotypes PheWAS code description Cases Controls OR (95% CI) per copy of the A allele P value
CKD CKD 55,072 325,644 1.22 (1.20–1.24) 2.09 × 10−105,a
CKD, stage III 35,945 349,403 1.23 (1.21–1.26) 2.82 × 10−83,a
CKD, stage IV 8655 385,145 1.23 (1.18–1.28) 1.54 × 10−21,a
Hypertension complications Hypertensive chronic kidney disease 29,791 351,260 1.19 (1.17–1.22) 4.31 × 10−51,a
Hypertensive heart or renal disease 51,684 317,609 1.10 (1.08–1.12) 3.68 × 10−27,a
UTIs UTI 34,293 333,364 0.93 (0.92–0.95) 4.35 × 10−11,a
Cystitis 3638 385,756 0.97 (0.92–1.03) 3.44 × 10−01
Acute cystitis 1096 391,828 0.92 (0.83–1.02) 1.26 × 10−01
Pyelonephritis 2232 391,619 0.91 (0.84–0.98) 9.18 × 10−03
Urinary calculi Urinary calculus 34,248 347,710 0.85 (0.83–0.86) 1.45 × 10−61,a
Calculus of the kidney 28,539 354,504 0.83 (0.81–0.85) 4.20 × 10−65,a
Calculus of the ureter 8299 383,418 0.81 (0.78–0.84) 5.22 × 10−27,a

CKD, chronic kidney disease; MVP, Million Veteran Program; OR, odds ratio; PheWAS, phenome-wide association study; UTI, urinary tract infection.

a

Represents phenotypes reaching PheWAS significance among non-Hispanic White female (5.86 × 10−05) and male patients (3.47 × 10−05) in the MVP.